Similar articles

• Biological Response Modifiers Programme and cancer chemotherapy.

  Oldham RK. Oldham RK. Int J Tissue React. 1982;4(3):173-88. Int J Tissue React. 1982. PMID: 6183193 Clinical Trial.
• Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.

  [No authors listed] [No authors listed] Natl Inst Health Consens Dev Conf Consens Statement. 1985;5(12):5 p.. Natl Inst Health Consens Dev Conf Consens Statement. 1985. PMID: 3908920 Review. No abstract available.
• Mathematics and oncology: a match for life?

  Piccart-Gebhart MJ. Piccart-Gebhart MJ. J Clin Oncol. 2003 Apr 15;21(8):1425-8. doi: 10.1200/JCO.2003.12.068. Epub 2003 Feb 13. J Clin Oncol. 2003. PMID: 12668653 No abstract available.
• Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.

  Newman LA, Mamounas EP. Newman LA, et al. Surg Clin North Am. 2007 Apr;87(2):279-305, vii. doi: 10.1016/j.suc.2007.02.005. Surg Clin North Am. 2007. PMID: 17498527
• High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.

  Brockstein BE, Williams SF. Brockstein BE, et al. Stem Cells. 1996 Jan;14(1):79-89. doi: 10.1002/stem.140079. Stem Cells. 1996. PMID: 8820954 Review.